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Table　1　The ratio of positive results of fungal colonization in sputum and presence of SMIT
AC CVA SBS FACC GER Psy UCC
Number of patients 29 22 21 13 4 4 13
Positive results of fungal cultures (%)
Aspergillus fumigatus 4 (14) 4 (18) 5 (24) 3 (23) 0 (0) 0 (0) 7 (54)
Basidiomycetous fungi 1 (4) 3 (15) 3 (15) 13 (100) 0 (0) 0 (0) 0 (0)
Candida 4 (14) 2 (9) 2 (10) 0 (0) 2 (50) 0 (0) 1 (8)
Aspergillus niger 4 (14) 2 (9) 5 (24) 0 (0) 0 (0) 1 (25) 5 (38)
Penicillium.spp. 0 (0) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 1 (8)
Aspergillus fl avus 1 (3) 0 (0) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0)
Presence of  SMIT 12 (41) 8 (36) 8 (38) 11 (85) 3 (75) 0 (0) 6 (46) 
SMIT, a sensation of mucus in the throat; AC, atopic cough; CVA, cough variant asthma; SBS, sinobronchial syndrome; FACC, fungus-
associated chronic cough; GER, gastroesophageal refl ux-associated cough; Psy, psychogenic cough; UCC, unexplained chronic cough.
Dear Editor
It is Time to Call Attention to the Clinical
Significance of Fungal Colonization in
Chronic Cough
Central sensitization, including abnormal laryngeal
paresthesia, is recognized as a potential mechanism
underlying chronic cough.1 Our recent study showed
that among the various types of laryngeal paresthe-
sia,2-4 a peculiar laryngeal sensation presenting as a
sensation of mucus in the throat (SMIT) is correlated
with fungal colonization in chronic cough patients.5
The presence of basidiomycetous (BM) fungi in in-
duced sputum has been reported to be an important
clinical finding associated with chronic idiopathic
cough (CIC). Further studies demonstrated that low-
dose itraconazole (ITCZ) therapy did not provide suf-
ficient relief of cough symptoms itself in CIC patients;
however, SMIT was successfully treated with the
therapy.6
Fungus-associated chronic cough (FACC) is a re-
cently introduced clinical concept encompassing a
number of chronic cough conditions7 including the
following manifestations: (i) chronic cough; (ii) the
presence of environmental fungi in sputum, particu-
larly BM fungi,8 which are well known to act as air-
borne allergens8; and (iii) a good clinical response to
antifungal drugs. Therefore, in FACC patients, SMIT
may be treated sufficiently together with cough itself
with antifungal drugs.
To clarify the clinical significance of fungal coloni-
zation in chronic cough patients, we report the re-
sults of a preliminary study regarding the recent
prevalence of chronic cough in Saiseikai Kanazawa
Hospital, and the positive rates of both fungal coloni-
zation and SMIT in chronic cough patients. The
medical records of 106 patients complaining of cough
lasting 8 weeks or longer, who visited our clinic from
1 April to 31 December 2012, were collected and re-
viewed retrospectively. The patients had a median
age of 51.0 (range: 19-82) years, and 60.7% were fe-
male. The causes of chronic cough were diagnosed
based on the diagnostic criteria of causes of chronic
cough recommended by the Japanese Cough Re-
search Society,9 and the American College of Chest
Physicians evidence-based practice guidelines. Defi-
nite FACC was diagnosed with the strict exclusion of
other causes of chronic cough. Unexplained chronic
cough (UCC) remained after diagnosis of sinobron-
chial syndrome (SBS), cough variant asthma (CVA),
atopic cough ( AC ) , or gastroesophageal reflux
(GER )-associated cough. These UCC patients in-
cluded a cluster of chronic cough patients whose spu-
tum culture yielded BM fungi and in whom antifungal
drugs showed sufficient efficacy. Such patients were
diagnosed as FACC and then excluded from UCC.
Among the 106 patients who were adequately as-
sessed, a diagnosis was made in 93 patients (87.7%):
AC in 29 (27.4%) ; CVA in 22 (20.8%) ; SBS in 21
(19.8%); FACC in 13 (12.3%); GER-associated cough
in 4 (3.8%); psychogenic cough in 4 (3.8%); and UCC
in 13 (12.3%) (Table 1). Fungal culture of the sputum
was obtained from 101 patients and the profiles were
as follows : Aspergillus fumigatus, 23 patients ; BM
fungi, 20 patients; Aspergillus niger, 17 patients; Can-
dida albicans, 11 patients; Penicillium spp., 2 patients;
and Aspergillus flavus, 2 patients. BM fungi were the
2nd most common type of fungi after A. fumigatus.
These environmental fungi were detected from pa-
tients with cough of various causes in various de-
grees.
Although we seldom experience the necessity for
eradicating Candida or Penicillium spp. from the spu-
tum of chronic cough patients, further research is
needed to determine whether A. fumigatus, which is
known to be associated with sensitization of asthma
or progression of ABPA, or A. niger, which has been
reported to be one of causative antigens of eosino-
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philic pneumonia, should also be eradicated. There-
fore, we decided not to diagnose such patients as
FACC but as UCC at present.
Similar to the other detected environmental fungi,
BM fungi are widely distributed around the world, it
is reasonable that they were detected from the spu-
tum samples obtained from various cough patients.
However, it is necessary to investigate whether addi-
tional therapies for FACC would also be efficacious
against SMIT, which is represented as a cough-
related laryngeal sensation of the patients with
chronic cough other than FACC.
In this study, there were no significant correlations
between the presence of SMIT and presence of spe-
cific fungi (A. fumigatus N.S. and BM fungi P = 0.08);
however, there were significant correlations between
SMIT and the presence of A. fumigatus or BM fungi
(P < 0.05). Therefore SMIT may predict colonization
by fungi, including BM fungi, in chronic cough pa-
tients. It is surprising that the positive ratio of BM
colonization in chronic cough patients was relatively
high, and that FACC was the fourth major cause of
chronic cough in this study.
In chronic cough patients suffering from SMIT, at-
tempts to detect fungal colonization in bronchial
specimens should be started at the beginning of the
diagnostic process of chronic cough rather than wait-
ing until after thorough systematic investigation for
new management of cough and cough-related laryn-
geal sensations.
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